Clario is a trusted brand that specializes in providing high-quality cardiac safety data, reporting services, and regulatory consultation for clinical trials, research studies, and drug trials. With over 50 years of scientific expertise, Clario offers reliable tools and solutions to accelerate the entire clinical trial process, from initiation to implementation. Their comprehensive approach to data collection ensures credible, compliant, and high-quality data that reduces variability and mitigates risk.

Clario's cardiac safety solutions are designed to address the #1 reason for drug development failure and post-market recalls. They offer a range of services, including arrhythmia analysis, blood pressure services, ECG monitoring, phase I/TQT cardiac assessment, and regulatory consultation with statistical analysis expertise. Their global capabilities, clinical and scientific expertise, patient-centric experiences, and proven results make them a trusted partner in the field.

With Clario, researchers can confidently collect reliable evidence, regardless of the therapeutic area or data source. Their goal is to improve patient safety and enrollment, increase data access, and deliver scientific-grade data to reduce timelines. With Clario, you can ensure that your clinical trial delivers more certain outcomes and brings new drugs and therapies to the market effectively